What is a normal blood glucose and insulin response to an Oral Glucose Tolerance Test (OGTT) in a non-diabetic adult?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Normal Blood Glucose and Insulin Response to OGTT in Non-Diabetic Adults

Blood Glucose Response

In a non-diabetic adult undergoing a 75-gram oral glucose tolerance test, the fasting plasma glucose should be less than 100 mg/dL (5.6 mmol/L), and the 2-hour post-load glucose should be less than 140 mg/dL (7.8 mmol/L). 1

Glucose Trajectory During OGTT

  • Fasting (baseline): Normal glucose is <100 mg/dL (5.6 mmol/L) 1
  • 2-hour post-load: Normal glucose is <140 mg/dL (7.8 mmol/L) 1, 2
  • Intermediate values (prediabetes): 2-hour glucose of 140-199 mg/dL (7.8-11.0 mmol/L) indicates impaired glucose tolerance (IGT) 1, 3
  • Diabetic range: 2-hour glucose ≥200 mg/dL (11.1 mmol/L) indicates diabetes 1

The glucose curve typically peaks between 30-60 minutes after the glucose load and then declines, returning toward baseline by 2 hours in individuals with normal glucose tolerance. 4

Insulin Response Pattern

Normal insulin response in non-diabetic adults shows a robust early-phase insulin secretion within the first 30 minutes after glucose ingestion, followed by sustained but lower insulin levels through the 2-hour period. 5

Key Insulin Response Characteristics

  • Early insulin response (0-30 minutes): The insulinogenic index (ratio of increment of plasma insulin in μU/mL to increment of blood glucose in mg/dL at 30 minutes) should be ≥0.5 in non-diabetic individuals 5

    • An insulinogenic index <0.5 indicates impaired insulin secretion and is characteristic of established diabetes 5
  • Insulin levels correlate with glucose levels: In non-diabetic individuals, insulin levels rise proportionally with glucose elevation, creating a characteristic relationship between glucose and insulin 5

  • Insulin suppresses lipolysis: Normal insulin response effectively suppresses nonesterified fatty acids (NEFAs), with clearance rates of approximately 11.9 μmol/L/min in individuals with normal glucose tolerance 6

    • Impaired suppression of NEFAs (clearance rates <7.6 μmol/L/min) indicates insulin resistance 6

Clinical Context and Interpretation

Important Caveats

  • Fasting glucose poorly predicts postprandial values: The correlation coefficient between fasting plasma glucose and 2-hour post-load glucose is only 0.50-0.70, meaning fasting values alone cannot reliably predict OGTT results 4

  • Age-related changes: Elderly individuals (>65 years) may show isolated postprandial hyperglycemia with normal fasting glucose, often associated with elevated fasting NEFAs and impaired NEFA suppression 6

  • Test standardization: The OGTT requires an 8-hour fast and uses 75 grams of anhydrous glucose dissolved in water 1, 2, 7

Diagnostic Thresholds Summary

The American Diabetes Association criteria define three categories based on 2-hour OGTT values: 1, 2

  • Normal glucose tolerance: <140 mg/dL (7.8 mmol/L)
  • Impaired glucose tolerance (prediabetes): 140-199 mg/dL (7.8-11.0 mmol/L)
  • Diabetes: ≥200 mg/dL (11.1 mmol/L)

Any abnormal result should be confirmed by repeat testing on a different day unless unequivocal hyperglycemia with symptoms is present. 1, 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.